CUIDADOS DE ENFERMERÍA AL PACIENTE CON HIPERTENSIÓN ARTERIAL EN URGENCIAS
Archivos
NO SE HA AUTORIZADO la consulta de los documentos asociados
Fecha
2022-07-05
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Jaén: Universidad de Jaén
Resumen
[ES] Este trabajo consiste en una revisión bibliográfica sistemática en la que se revisaron 15 artículos. Se obtuvieron un total de 13606 resultados para la búsqueda de evidencias científicas. Se descartaron más de 13000 resultados por filtros, criterios de inclusión y exclusión y criterios de calidad. Los resultados obtenidos mostraron que la falta de adherencia a tratamiento antihipertensivo incrementa el riesgo de sufrir una crisis hipertensiva significativamente (p˂0`05) también se observó una asociación significativa entre la falta de adherencia terapéutica o la adherencia terapéutica inadecuada y el aumento de hospitalizaciones derivadas de complicaciones de la HTA. Respecto al tratamiento farmacológico, se estableció que el captopril es el fármaco de primera elección en los casos de crisis hipertensivas. Se concluyó que se necesitan más estudios a largo plazo que posibiliten esclarecer la diferencia entre urgencia hipertensiva y emergencia hipertensiva y cuál es el tratamiento más efectivo a largo plazo para prevenir la recurrencia de las crisis hipertensivas.
[EN] The World Health Organization (WHO), in 2013, established that HTN affects one billion people around the world, of which nine million die annually from this disease. In Spain, between 1993 and 2017, the prevalence of HT increased by 75% in people over 15 years of age. More than 70% of hypertensive people in treatment have low adherence to it as well as ineffective control of BP levels. The results obtained showed that the lack of adherence to antihypertensive treatment increases the risk of suffering a hypertensive crisis significantly (p˂0`05), a significant association was also observed between the lack of therapeutic adherence or inadequate therapeutic adherence and the increase in hospitalizations. derived from complications of hypertension. Regarding drug treatment, it was established that captopril is the drug of first choice in cases of hypertensive crisis. It was concluded that more long-term studies are needed to clarify the difference between hypertensive emergency and hypertensive emergency and which is the most effective long-term studies are needed to clarify the difference between hypertensive emergency and hypertensive emergency and which is the most effective long-term treatment to prevent the recurrence of hypertensive crises.
[EN] The World Health Organization (WHO), in 2013, established that HTN affects one billion people around the world, of which nine million die annually from this disease. In Spain, between 1993 and 2017, the prevalence of HT increased by 75% in people over 15 years of age. More than 70% of hypertensive people in treatment have low adherence to it as well as ineffective control of BP levels. The results obtained showed that the lack of adherence to antihypertensive treatment increases the risk of suffering a hypertensive crisis significantly (p˂0`05), a significant association was also observed between the lack of therapeutic adherence or inadequate therapeutic adherence and the increase in hospitalizations. derived from complications of hypertension. Regarding drug treatment, it was established that captopril is the drug of first choice in cases of hypertensive crisis. It was concluded that more long-term studies are needed to clarify the difference between hypertensive emergency and hypertensive emergency and which is the most effective long-term studies are needed to clarify the difference between hypertensive emergency and hypertensive emergency and which is the most effective long-term treatment to prevent the recurrence of hypertensive crises.